In this issue:
Methotrexate safety and efficacy meta-analyses
Biologic drug survival in daily practice
Tofacitinib maintains efficacy through 2 years
Tofacitinib: consistent efficacy across patient subgroups
Comparing effectiveness of biologics in a real-world setting
Biologics ameliorate myocardial dysfunction in severe psoriasis
Exploring genetic factors and therapeutic responses in psoriasis
Systemic cyclosporin A effective, safe in paediatric psoriasis
Clinical meaningfulness of complete skin clearance in psoriasis
Vitamin D, PBMCs and cytokines in psoriasis
Progression of RORγ inverse agonist as a topical therapeutic
Please login below to download this issue (PDF)